We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has granted premarket approval to Thermo Fisher Scientific's Oncomine Dx Target Test as a companion diagnostic to help identify nonsmall-cell lung cancer (NSCLC) patients whose tumors carry certain mutations for potential treatment with Rybrevant (amivantamab-vmjw), Janssen’s targeted therapy. Read More
Several recent lung cancer clinical trials combining radiotherapy with drug therapy demonstrate significant improvements in overall and progression-free survival, the company said. Read More
If present in the sample, RNA from the SARS-CoV-2 virus that causes COVID-19 infection is detected using an approved molecular diagnostic test. Read More
Testing to support the FDA submission included patients with conditions, such as chronic respiratory pulmonary disease, asthma, congestive heart failure and anxiety, the company said. Read More
Directed Systems’ Hypotension Decision Assist software supports anesthesiologists by providing intuitive visualization on a single display of at-a-glance, time-critical information about emerging critical cardiovascular situations in the operating room. Read More
Qiagen’s QuantiFERON assay can detect CD4+ and CD8+ T-cell responses, which allows a comprehensive assessment of the immunity produced by the COVID-19 vaccine. Read More